The Cancer Biomarker Market is expected to record a CAGR of nearly 13% over the forecast period. Certain factors driving the market growth include increased cancer incidence worldwide, increased acceptance of cancer treatment in developing countries, medical paradigm shift from disease diagnosis to risk assessment or early diagnosis, and increased use of biomarkers in drug […]
